Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
Journey Medical Corporation is a commercial-stage pharmaceutical company that develops and commercializes FDA-approved prescription treatments for dermatological conditions. It serves patients and healthcare professionals with a portfolio of therapies for common skin conditions and wound healing.
0 investors
JSK Therapeutics is a privately held drug development company working on pharmaceutical products, with funding tied to cancer-related research grants. It has received awards from the National Cancer Institute and backing from seed funds, state technology boards, and angel investors.
0 investors
JucaBio is a privately held, clinical-stage biopharmaceutical company using a hub-and-spoke model to acquire differentiated drug assets and build subsidiaries that run focused clinical development programs. It targets drugs addressing significant unmet medical needs.
0 investors
Jupiter Biomedical Research is a drug development company with patents for two therapeutic candidates: JBR-102, an oral treatment for glioblastoma multiforme and other brain tumors, and JBR-201, an antiviral treatment for measles virus infections and related neurological diseases. The company is pursuing regulatory approval from Health Canada and the FDA for its lead cancer candidate while advancing preclinical development of its antiviral program.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Kairos Pharma is a clinical-stage biopharmaceutical company developing therapies to overcome resistance to cancer drugs and reverse cancer-induced immune suppression. Its pipeline includes ENV105, a CD105 antibody in Phase 2 prostate cancer and Phase 1 lung cancer trials, and immunotherapy candidates KROS101 and KROS201 for oncology indications including glioblastoma.
0 investors
0 investors
0 investors
Kamal Therapeutics is developing an intravenous recombinant human decorin as a treatment for dystrophic epidermolysis bullosa. It operates as a biotechnology company focused on therapeutics for this genetic skin disorder.
0 investors
0 investors
0 investors
0 investors
KBS Research is a physician-led R&D company that develops polyphenol-based formulations targeting the biological mechanisms behind digestive and metabolic conditions such as IBS, SIBO, bloating, and GERD. It validates its clinically studied products (including Atrantil and Re:flux) through structured human studies combining gastroenterology, microbiome science, and polyphenol chemistry.
0 investors
KDx Diagnostics develops diagnostic tests for early detection and management of cancer, including the URO17 non-invasive urine test for bladder cancer based on the Keratin 17 biomarker. The URO17 test is offered in the US as a Laboratory Developed Test through reference laboratories and as a CE-IVD kit outside the US.
0 investors